How choosing the right transfection reagent can drastically bring down costs of AAV manufacturing

Published: 23 November 2021
FastFacts
Maxime Dumont

Watch the video or read the poster to learn:

  • How to choose the right transfection reagent
  • Impact of transfection performance on viral vector manufacturing costs and costs per dose
  • How novel technology can reduce AAV manufacturing costs

Maxime Dumont is a cell and gene therapy product manager at Polyplus-transfection®. With two master’s degrees in biochemistry, project management and marketing of pharmaceutical products, Maxime is managing the CGT transfection reagent portfolio for over 4 years.

Please note all fields marked with an * are mandatory

View article

Already registered? Login

If you have any problem accessing our content, please email info@insights.bio